Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Nasdaq: SHPH · Pharmaceutical Preparations · Gaithersburg, MD · filing with the SEC since 2019
Filings
252 filings since 2017 beside 56 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 48 days after the quarter ended. The proxy statement was last filed Aug 13, 2026.
Filings a yearinsider forms included
25556558852
2026 counts to Nov 13, 2026.
Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Nov 6, 2026.Listing warning from its exchange (8-K item 3.01): 7 times in the last 36 months, the newest Aug 28, 2026.Officer or director change (8-K item 5.02): 15 times in the last 36 months, the newest May 7, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Jul 16, 2024.SEC letters: 18 in the last 36 months, the newest Feb 13, 2026.A late-filing notice, Form NT 10-Q, filed Aug 17, 2026.A late-filing notice, Form NT 10-Q, filed Aug 13, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 24, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Sep 9, 2026
Aug 28, 2026
8-K items 3.01, 7.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Aug 17, 2026
8-K/A items 2.01, 9.01
Purchase or sale of a business completed · Current report, amended
May 1, 2026
Jul 1, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Jun 25, 2026
Jun 11, 2026
8-K items 3.03, 5.03, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Jun 10, 2026
May 7, 2026
8-K items 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 9.01
Major agreement signed; Purchase or sale of a business completed; Shares sold without registration; Change to shareholders' rights; Officer or director change; Charter, bylaw or fiscal-year change · Current report
May 1, 2026
May 1, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Apr 30, 2026
Mar 10, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Mar 5, 2026
40 of 252 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.